Applications of neural and mesenchymal stem cells in the treatment of gliomas

References

• DeAngelis LM. Brain tumors. N. Engl. J. Med.344(2), 114–123 (2001).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med.352(10), 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Than KD, Weingart JD et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J. Neurosurg.110(3), 583–588 (2009).
   PubMed Web of Science ®Google Scholar
• Kornblith PL, Walker M. Chemotherapy for malignant gliomas. J. Neurosurg.68(1), 1–17 (1988).
   PubMed Web of Science ®Google Scholar
• Wen PY, Kesari S. Malignant gliomas in adults. N. Engl. J. Med.359(5), 492–507 (2008).
   PubMed Web of Science ®Google Scholar
• Holland EC. Glioblastoma multiforme: the terminator. Proc. Natl Acad. Sci. USA97(12), 6242–6244 (2000).
   PubMed Web of Science ®Google Scholar
• Kaye AH, Laws ER. Historical perspective. In: Brain Tumors: An Encyclopedic Approach. Kaye AH, Laws ER (Eds). Churchill Livingstone, NY, USA 3–8 (2001).
   Google Scholar
• Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol.114(5), 443–458 (2007).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Chaichana KL, Attenello FJ et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery63(4), 700–707 (2008).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Chaichana KL, Gathinji M et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J. Neurosurg.110(1), 156–162 (2009).
   PubMed Web of Science ®Google Scholar
• Salazar OM, Rubin P. The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int. J. Radiat. Oncol. Biol. Phys.1(7–8), 627–637 (1976).
   PubMed Web of Science ®Google Scholar
• Cedzich C, Taniguchi M, Schafer S, Schramm J. Somatosensory evoked potential phase reversal and direct motor cortex stimulation during surgery in and around the central region. Neurosurgery38(5), 962–970 (1996).
   PubMed Web of Science ®Google Scholar
• Fadul C, Wood J, Thaler H et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology38(9), 1374–1379 (1988).
   PubMed Web of Science ®Google Scholar
• Sawaya R, Hammoud M, Schoppa D et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery42(5), 1044–1055 (1998).
   PubMed Web of Science ®Google Scholar
• Dandy W. Removal of right cerebral hemispheres for certain tumors with hemiplegia: preliminary report. JAMA90, 823–825 (1928).
   Google Scholar
• Karim AB, Maat B, Hatlevoll R et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int. J. Radiat. Oncol. Biol. Phys.36(3), 549–556 (1996).
   PubMed Web of Science ®Google Scholar
• Shaw E, Arusell R, Scheithauer B et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J. Clin. Oncol.20(9), 2267–2276 (2002).
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Burger PC, Green SB, Cairncross JG. Malignant glioma: who benefits from adjuvant chemotherapy? Ann. Neurol.44(4), 691–695 (1998).
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Than KD, Weingart JD et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J. Neurosurg.110(3), 583–588 (2009).
   PubMed Web of Science ®Google Scholar
• Recht LD, Lew R, Smith TW. Suspected low-grade glioma: is deferring treatment safe? Ann. Neurol.31(4), 431–436 (1992).
   PubMed Web of Science ®Google Scholar
• Laing RW, Warrington AP, Graham J et al. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (Phase I/II study). Radiother. Oncol.27(1), 22–29 (1993).
   PubMed Web of Science ®Google Scholar
• Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant.18(Suppl. 3), S1–S5 (1996).
   Google Scholar
• Groothuis DR. The blood–brain and blood–tumor barriers: a review of strategies for increasing drug delivery. Neuro. Oncol.2(1), 45–59 (2000).
   PubMed Web of Science ®Google Scholar
• Pardridge WM. CNS drug design based on principles of blood–brain barrier transport. J. Neurochem.70(5), 1781–1792 (1998).
   PubMed Web of Science ®Google Scholar
• Lesniak MS, Brem H. Targeted therapy for brain tumours. Nat. Rev. Drug. Discov.3(6), 499–508 (2004).
   PubMed Web of Science ®Google Scholar
• Parsa AT, Waldron JS, Panner A et al. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat. Med.13(1), 84–88 (2007).
   PubMed Web of Science ®Google Scholar
• Fecci PE, Mitchell DA, Whitesides JF et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res.66(6), 3294–3302 (2006).
   PubMed Web of Science ®Google Scholar
• Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron58(6), 832–846 (2008).
   PubMed Web of Science ®Google Scholar
• Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl Acad. Sci. USA97(23), 12846–12851 (2000).
   PubMed Web of Science ®Google Scholar
• Dietrich J, Imitola J, Kesari S. Mechanisms of disease: the role of stem cells in the biology and treatment of gliomas. Nat. Clin. Pract. Oncol.5(7), 393–404 (2008).
   PubMedGoogle Scholar
• Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad. Sci. USA100(25), 15178–15183 (2003).
   PubMed Web of Science ®Google Scholar
• Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res.64(19), 7011–7021 (2004).
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res.63(18), 5821–5828 (2003).
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature432(7015), 396–401 (2004).
   PubMed Web of Science ®Google Scholar
• Tu SM, Lin SH, Logothetis CJ. Stem-cell origin of metastasis and heterogeneity in solid tumours. Lancet Oncol.3(8), 508–513 (2002).
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature444(7120), 756–760 (2006).
   PubMed Web of Science ®Google Scholar
• Xie Z, Chin LS. Molecular and cell biology of brain tumor stem cells: lessons from neural progenitor/stem cells. Neurosurg. Focus24(3–4), E25 (2008).
   Google Scholar
• Sakariassen PO, Immervoll H, Chekenya M. Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia9(11), 882–892 (2007).
   PubMed Web of Science ®Google Scholar
• Chaichana KL, McGirt MJ, Frazier J et al. Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J. Neurooncol.89(2), 219–224 (2008).
   PubMed Web of Science ®Google Scholar
• Bachoo RM, Maher EA, Ligon KL et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell1(3), 269–277 (2002).
   PubMed Web of Science ®Google Scholar
• Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature374(6520), 367–370 (1995).
   PubMed Web of Science ®Google Scholar
• Yip S, Aboody KS, Burns M et al. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J.9(3), 189–204 (2003).
   PubMedGoogle Scholar
• Nakamura K, Ito Y, Kawano Y et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther.11(14), 1155–1164 (2004).
   PubMed Web of Science ®Google Scholar
• Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res.65(8), 3307–3318 (2005).
   PubMed Web of Science ®Google Scholar
• Xu F, Zhu JH. Stem cells tropism for malignant gliomas. Neurosci. Bull.23(6), 363–369 (2007).
   PubMedGoogle Scholar
• Yip S, Sabetrasekh R, Sidman RL, Snyder EY. Neural stem cells as novel cancer therapeutic vehicles. Eur. J. Cancer42(9), 1298–1308 (2006).
   PubMed Web of Science ®Google Scholar
• Erlandsson A, Larsson J, Forsberg-Nilsson K. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp. Cell Res.301(2), 201–210 (2004).
   PubMed Web of Science ®Google Scholar
• Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest.113(9), 1364–1374 (2004).
   PubMed Web of Science ®Google Scholar
• Serfozo P, Schlarman MS, Pierret C, Maria BL, Kirk MD. Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines. Cancer Cell Int.6, 1 (2006).
   PubMedGoogle Scholar
• Heese O, Disko A, Zirkel D, Westphal M, Lamszus K. Neural stem cell migration toward gliomas in vitro. Neuro. Oncol.7(4), 476–484 (2005).
   PubMedGoogle Scholar
• Widera D, Holtkamp W, Entschladen F et al. MCP-1 induces migration of adult neural stem cells. Eur. J. Cell. Biol.83(8), 381–387 (2004).
   PubMed Web of Science ®Google Scholar
• Palumbo R, Galvez BG, Pusterla T et al. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation. J. Cell. Biol.179(1), 33–40 (2007).
   PubMed Web of Science ®Google Scholar
• Kendall SE, Najbauer J, Johnston HF et al. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells26(6), 1575–1586 (2008).
   PubMed Web of Science ®Google Scholar
• Chicoine MR, Silbergeld DL. Mitogens as motogens. J. Neurooncol.35(3), 249–257 (1997).
   PubMed Web of Science ®Google Scholar
• Boockvar JA, Kapitonov D, Kapoor G et al. Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol. Cell. Neurosci.24(4), 1116–1130 (2003).
   PubMed Web of Science ®Google Scholar
• Schichor C, Birnbaum T, Etminan N et al. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exp. Neurol.199(2), 301–310 (2006).
   PubMed Web of Science ®Google Scholar
• Birnbaum T, Roider J, Schankin CJ et al. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J. Neurooncol.83(3), 241–247 (2007).
   PubMed Web of Science ®Google Scholar
• Schmidt NO, Przylecki W, Yang W et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia7(6), 623–629 (2005).
   PubMed Web of Science ®Google Scholar
• Ziu M, Schmidt NO, Cargioli TG et al. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J. Neurooncol.79(2), 125–133 (2006).
   PubMed Web of Science ®Google Scholar
• Ries C, Egea V, Karow M et al. MMP-2, MT1-MMP and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood109(9), 4055–4063 (2007).
   PubMed Web of Science ®Google Scholar
• Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med.9(6), 702–712 (2003).
   PubMed Web of Science ®Google Scholar
• Wysoczynski M, Reca R, Ratajczak J et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood105(1), 40–48 (2005).
   PubMed Web of Science ®Google Scholar
• Son BR, Marquez-Curtis LA, Kucia M et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells24(5), 1254–1264 (2006).
   PubMed Web of Science ®Google Scholar
• Imitola J, Raddassi K, Park KI et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc. Natl Acad. Sci. USA101(52), 18117–18122 (2004).
   PubMed Web of Science ®Google Scholar
• Allport JR, Shinde Patil VR, Weissleder R. Murine neuronal progenitor cells are preferentially recruited to tumor vasculature via α4-integrin and SDF-1α-dependent mechanisms. Cancer Biol. Ther.3(9), 838–844 (2004).
   PubMed Web of Science ®Google Scholar
• Rempel SA, Dudas S, Ge S, Gutierrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin. Cancer Res.6(1), 102–111 (2000).
   PubMed Web of Science ®Google Scholar
• Fears CY, Sontheimer HW, Bullard DC, Gladson CL. Could labeled neuronal progenitor cells be used to target glioma tumor endothelium? Cancer Biol. Ther.3(9), 845–846 (2004).
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Yuan X, Kabos P et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia6(3), 287–293 (2004).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem.277(51), 49481–49487 (2002).
   PubMed Web of Science ®Google Scholar
• Rubin JB, Kung AL, Klein RS et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc. Natl Acad. Sci. USA100(23), 13513–13518 (2003).
   PubMed Web of Science ®Google Scholar
• Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells. Mol. Cancer Res.2(6), 327–338 (2004).
   PubMed Web of Science ®Google Scholar
• Liang Z, Wu T, Lou H et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res.64(12), 4302–4308 (2004).
   PubMed Web of Science ®Google Scholar
• Becker AJ, Mc CE, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature197, 452–454 (1963).
   PubMed Web of Science ®Google Scholar
• Siminovitch L, McCulloch EA, Till JE. The distribution of colony-forming cells among spleen colonies. J. Cell. Physiol.62, 327–336 (1963).
   PubMed Web of Science ®Google Scholar
• Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc. Natl Acad. Sci. USA94(23), 12425–12430 (1997).
   PubMed Web of Science ®Google Scholar
• Levison SW, Goldman JE. Multipotential and lineage restricted precursors coexist in the mammalian perinatal subventricular zone. J. Neurosci. Res.48(2), 83–94 (1997).
   PubMedGoogle Scholar
• Doyle KL, Khan M, Cunningham AM. Expression of the intermediate filament protein nestin by sustentacular cells in mature olfactory neuroepithelium. J. Comp. Neurol.437(2), 186–195 (2001).
   PubMedGoogle Scholar
• Sakakibara S, Okano H. Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J. Neurosci.17(21), 8300–8312 (1997).
   PubMed Web of Science ®Google Scholar
• Uchida K, Momiyama T, Okano H et al. Potential functional neural repair with grafted neural stem cells of early embryonic neuroepithelial origin. Neurosci. Res.52(3), 276–286 (2005).
   PubMedGoogle Scholar
• Palm K, Salin-Nordstrom T, Levesque MF, Neuman T. Fetal and adult human CNS stem cells have similar molecular characteristics and developmental potential. Brain Res. Mol. Brain Res.78(1–2), 192–195 (2000).
   PubMedGoogle Scholar
• Pevny LH, Sockanathan S, Placzek M, Lovell-Badge R. A role for SOX1 in neural determination. Development125(10), 1967–1978 (1998).
   PubMedGoogle Scholar
• Zappone MV, Galli R, Catena R et al. Sox2 regulatory sequences direct expression of a β-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development127(11), 2367–2382 (2000).
   PubMed Web of Science ®Google Scholar
• Cai J, Wu Y, Mirua T et al. Properties of a fetal multipotent neural stem cell (NEP cell). Dev. Biol.251(2), 221–240 (2002).
   PubMedGoogle Scholar
• Parker MA anderson JK, Corliss DA et al. Expression profile of an operationally-defined neural stem cell clone. Exp. Neurol.194(2), 320–332 (2005).
   PubMedGoogle Scholar
• Gottlieb DI. Large-scale sources of neural stem cells. Annu. Rev. Neurosci.25, 381–407 (2002).
   PubMed Web of Science ®Google Scholar
• Palmer TD, Schwartz PH, Taupin P et al. Cell culture. Progenitor cells from human brain after death. Nature411(6833), 42–43 (2001).
   PubMed Web of Science ®Google Scholar
• Kukekov VG, Laywell ED, Suslov O et al. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol.156(2), 333–344 (1999).
   PubMed Web of Science ®Google Scholar
• Eriksson PS, Perfilieva E, Bjork-Eriksson T et al. Neurogenesis in the adult human hippocampus. Nat. Med.4(11), 1313–1317 (1998).
   PubMed Web of Science ®Google Scholar
• Antel JP, Nalbantoglu J, Olivier A. Neuronal progenitors – learning from the hippocampus. Nat. Med.6(3), 249–250 (2000).
   PubMed Web of Science ®Google Scholar
• Nunes MC, Roy NS, Keyoung HM et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med.9(4), 439–447 (2003).
   PubMed Web of Science ®Google Scholar
• Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA97(26), 14720–14725 (2000).
   PubMed Web of Science ®Google Scholar
• Flax JD, Aurora S, Yang C et al. Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat. Biotechnol.16(11), 1033–1039 (1998).
   PubMed Web of Science ®Google Scholar
• Tropepe V, Coles BL, Chiasson BJ et al. Retinal stem cells in the adult mammalian eye. Science287(5460), 2032–2036 (2000).
   PubMed Web of Science ®Google Scholar
• Reubinoff BE, Itsykson P, Turetsky T et al. Neural progenitors from human embryonic stem cells. Nat. Biotechnol.19(12), 1134–1140 (2001).
   PubMed Web of Science ®Google Scholar
• Quinones-Hinojosa A, Sanai N, Soriano-Navarro M et al. Cellular composition and cytoarchitecture of the adult human subventricular zone: a niche of neural stem cells. J. Comp. Neurol.494(3), 415–434 (2006).
   PubMed Web of Science ®Google Scholar
• Sanai N, Tramontin AD, Quinones-Hinojosa A et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature427(6976), 740–744 (2004).
   PubMed Web of Science ®Google Scholar
• Quinones-Hinojosa A, Sanai N, Gonzalez-Perez O, Garcia-Verdugo JM. The human brain subventricular zone: stem cells in this niche and its organization. Neurosurg. Clin. N. Am.18(1), 15–20, vii (2007).
   PubMedGoogle Scholar
• Lee A, Kessler JD, Read TA et al. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci.8(6), 723–729 (2005).
   PubMed Web of Science ®Google Scholar
• Bedard A, Parent A. Evidence of newly generated neurons in the human olfactory bulb. Brain Res. Dev. Brain Res.151(1–2), 159–168 (2004).
   PubMedGoogle Scholar
• Colombo E, Giannelli SG, Galli R et al. Embryonic stem-derived versus somatic neural stem cells: a comparative analysis of their developmental potential and molecular phenotype. Stem Cell24(4), 825–834 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang Y, Henderson D, Blackstad M et al. Neuroectodermal differentiation from mouse multipotent adult progenitor cells. Proc. Natl Acad. Sci. USA100(Suppl. 1), 11854–11860 (2003).
   PubMed Web of Science ®Google Scholar
• Kogler G, Sensken S, Airey JA et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med.200(2), 123–135 (2004).
   PubMed Web of Science ®Google Scholar
• Joannides A, Gaughwin P, Schwiening C et al. Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet364(9429), 172–178 (2004).
   PubMed Web of Science ®Google Scholar
• Renfranz PJ, Cunningham MG, McKay RD. Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell66(4), 713–729 (1991).
   PubMed Web of Science ®Google Scholar
• Rosario CM, Yandava BD, Kosaras B et al. Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development124(21), 4213–4224 (1997).
   PubMedGoogle Scholar
• Yandava BD, Billinghurst LL, Snyder EY. ‘Global’ cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc. Natl Acad. Sci. USA96(12), 7029–7034 (1999).
   PubMed Web of Science ®Google Scholar
• Temple S. The development of neural stem cells. Nature14(6859), 112–117 (2001).
   Google Scholar
• Ma W, Fitzgerald W, Liu QY et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp. Neurol.190(2), 276–288 (2004).
   PubMed Web of Science ®Google Scholar
• Zlomanczuk P, Mrugala M, de la Iglesia HO et al. Transplanted clonal neural stem-like cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus. Exp. Neurol.174(2), 162–168 (2002).
   PubMedGoogle Scholar
• Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol.20(11), 1103–1110 (2002).
   PubMed Web of Science ®Google Scholar
• Kim DE, Schellingerhout D, Ishii K, Shah K, Weissleder R. Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke35(4), 952–957 (2004).
   PubMed Web of Science ®Google Scholar
• Martinez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A. Human neural stem and progenitor cells: in vitro and in vivo properties and potential for gene therapy and cell replacement in the CNS. Curr. Gene Ther.1(3), 279–299 (2001).
   PubMedGoogle Scholar
• Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med.10(Suppl.), S42–S50 (2004).
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol.4(5), 267–274 (1976).
   PubMed Web of Science ®Google Scholar
• Gronthos S, Graves SE, Ohta S, Simmons PJ. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood84(12), 4164–4173 (1994).
   PubMed Web of Science ®Google Scholar
• Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG. Bone marrow stromal cells: characterization and clinical application. Crit. Rev. Oral Biol. Med.10(2), 165–181 (1999).
   PubMedGoogle Scholar
• Huss R. Perspectives on the morphology and biology of CD34-negative stem cells. J. Hematother. Stem Cell Res.9(6), 783–793 (2000).
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science284(5411), 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Brown SE, Tong W, Krebsbach PH. The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs189(1–4), 256–260 (2009).
   PubMed Web of Science ®Google Scholar
• Tocci A, Forte L. Mesenchymal stem cell: use and perspectives. Hematol. J.4(2), 92–96 (2003).
   PubMedGoogle Scholar
• Conget PA, Minguell JJ. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp. Hematol.28(4), 382–390 (2000).
   PubMed Web of Science ®Google Scholar
• Tondreau T, Meuleman N, Delforge A et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression and plasticity. Stem Cells23(8), 1105–1112 (2005).
   PubMed Web of Science ®Google Scholar
• Miao Z, Jin J, Chen L et al. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int.30(9), 681–687 (2006).
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell13(12), 4279–4295 (2002).
   PubMed Web of Science ®Google Scholar
• Pisati F, Belicchi M, Acerbi F et al. Effect of human skin-derived stem cells on vessel architecture, tumor growth and tumor invasion in brain tumor animal models. Cancer Res.67(7), 3054–3063 (2007).
   PubMed Web of Science ®Google Scholar
• Bianchi G, Muraglia A, Daga A et al. Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Regen.9(6), 460–466 (2001).
   PubMedGoogle Scholar
• Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood98(9), 2615–2625 (2001).
   PubMed Web of Science ®Google Scholar
• Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol.109(1), 235–242 (2000).
   PubMed Web of Science ®Google Scholar
• Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells24(5), 1294–1301 (2006).
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim JH, Lee JK et al. Overexpression of CXC chemokine receptors is required for the superior glioma- tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev.18(3), 511–519 (2009).
   PubMedGoogle Scholar
• Glass R, Synowitz M, Kronenberg G et al. Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J. Neurosci.25(10), 2637–2646 (2005).
   PubMed Web of Science ®Google Scholar
• Weinstein DE, Shelanski ML, Liem RK. C17, a retrovirally immortalized neuronal cell line, inhibits the proliferation of astrocytes and astrocytoma cells by a contact-mediated mechanism. Glia3(2), 130–139 (1990).
   PubMedGoogle Scholar
• Staflin K, Honeth G, Kalliomaki S et al. Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res.64(15), 5347–5354 (2004).
   PubMed Web of Science ®Google Scholar
• Barresi V, Belluardo N, Sipione S et al. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther.10(5), 396–402 (2003).
   PubMed Web of Science ®Google Scholar
• Li S, Tokuyama T, Yamamoto J et al. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther.12(7), 600–607 (2005).
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Woiciechowski C, Sena-Esteves M et al. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol. Ther.1(4), 347–357 (2000).
   PubMed Web of Science ®Google Scholar
• Uhl M, Weiler M, Wick W et al. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem. Biophys. Res. Commun.328(1), 125–129 (2005).
   PubMed Web of Science ®Google Scholar
• Manome Y, Wen PY, Dong Y et al. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat. Med.2(5), 567–573 (1996).
   PubMed Web of Science ®Google Scholar
• Aghi M, Hochberg F, Breakefield XO. Prodrug activation enzymes in cancer gene therapy. J. Gene Med.2(3), 148–164 (2000).
   PubMed Web of Science ®Google Scholar
• Davidson BL, Breakefield XO. Viral vectors for gene delivery to the nervous system. Nat. Rev. Neurosci.4(5), 353–364 (2003).
   PubMed Web of Science ®Google Scholar
• Rooseboom M, Commandeur JN, Vermeulen NP. Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol. Rev.56(1), 53–102 (2004).
   PubMed Web of Science ®Google Scholar
• Miletic H, Fischer Y, Litwak S et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther.15(7), 1373–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Lynch WP, Sharpe AH, Snyder EY. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J. Virol.73(8), 6841–6851 (1999).
   PubMedGoogle Scholar
• Tyler MA, Ulasov IV, Sonabend AM et al. Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo. Gene Ther.16(2), 262–278 (2009).
   PubMed Web of Science ®Google Scholar
• Arnhold S, Hilgers M, Lenartz D et al. Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy. Cell Transplant.12(8), 827–837 (2003).
   PubMedGoogle Scholar
• Sonabend AM, Ulasov IV, Tyler MA et al. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells26(3), 831–841 (2008).
   PubMed Web of Science ®Google Scholar
• Faber C, Terao E, Morga E, Heuschling P. Interleukin-4 enhances the in vitro precursor cell recruitment for tumor-specific T lymphocytes in patients with glioblastoma. J. Immunother.23(1), 11–16 (2000).
   PubMedGoogle Scholar
• Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med.6(4), 447–450 (2000).
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Kabos P, Kabosova A et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res.62(20), 5657–5663 (2002).
   PubMed Web of Science ®Google Scholar
• Langowski JL, Zhang X, Wu L et al. IL-23 promotes tumour incidence and growth. Nature442(7101), 461–465 (2006).
   PubMed Web of Science ®Google Scholar
• Yuan X, Hu J, Belladonna ML, Black KL, Yu JS. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res.66(5), 2630–2638 (2006).
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Pai RC, Fong S et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest.104(2), 155–162 (1999).
   PubMed Web of Science ®Google Scholar
• Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med.5(2), 157–163 (1999).
   PubMed Web of Science ®Google Scholar
• Ehtesham M, Kabos P, Gutierrez MA et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res.62(24), 7170–7174 (2002).
   PubMed Web of Science ®Google Scholar
• Kim I, Kim H, S. I, Snyder EY, Park KI. Induction of intracranial glioblastoma apoptosis by transplantation of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) expressing human neural stem cells (NSCs). Presented at: Annual Meeting of Society for Neuroscience. San Diego, CA, USA, 23–27 October 2004.
   Google Scholar
• Shah K, Tung CH, Breakefield XO, Weissleder R. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol. Ther.11(6), 926–931 (2005).
   PubMed Web of Science ®Google Scholar
• Kock N, Kasmieh R, Weissleder R, Shah K. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia9(5), 435–442 (2007).
   PubMedGoogle Scholar
• Corsten MF, Miranda R, Kasmieh R et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res.67(19), 8994–9000 (2007).
   PubMed Web of Science ®Google Scholar
• Hingtgen S, Ren X, Terwilliger E et al. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. Mol. Cancer Ther.7(11), 3575–3585 (2008).
   PubMed Web of Science ®Google Scholar
• Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu. Rev. Biochem.67, 227–264 (1998).
   PubMed Web of Science ®Google Scholar
• Belardelli F, Ferrantini M, Proietti E, Kirkwood JM. Interferon-α in tumor immunity and immunotherapy. Cytokine Growth Factor Rev.13(2), 119–134 (2002).
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Gresser I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J. Natl Cancer Inst.81(7), 497–502 (1989).
   PubMed Web of Science ®Google Scholar
• Streck CJ, Dickson PV, Ng CY et al. Antitumor efficacy of AAV-mediated systemic delivery of interferon-β. Cancer Gene Ther.13(1), 99–106 (2006).
   PubMedGoogle Scholar
• Dickson PV, Hamner JB, Burger RA et al. Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-β and restricts tumor growth in a murine model of disseminated neuroblastoma. J. Pediatr. Surg.42(1), 48–53 (2007).
   PubMedGoogle Scholar
• Kurozumi K, Nakamura K, Tamiya T et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther.11(1), 96–104 (2005).
   PubMed Web of Science ®Google Scholar
• Honma T, Honmou O, Iihoshi S et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp. Neurol.199(1), 56–66 (2006).
   PubMed Web of Science ®Google Scholar
• Xu G, Jiang XD, Xu Y et al. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats. Cell Biol. Int.33(4), 466–474 (2008).
   PubMedGoogle Scholar
• Kim SM, Lim JY, Park SI et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res.68(23), 9614–9623 (2008).
   PubMed Web of Science ®Google Scholar
• Sato H, Kuwashima N, Sakaida T et al. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors. Cancer Gene Ther.12(9), 757–768 (2005).
   PubMed Web of Science ®Google Scholar
• Kang SG, Jeun SS, Lim JY et al. Cytotoxicity of rat marrow stromal cells against malignant glioma cells. Childs Nerv. Syst.21(7), 528–538 (2005).
   PubMed Web of Science ®Google Scholar
• Kang SG, Jeun SS, Lim JY et al. Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells. Childs Nerv. Syst.24(3), 293–302 (2008).
   PubMed Web of Science ®Google Scholar
• Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell92(3), 391–400 (1998).
   PubMed Web of Science ®Google Scholar
• Bello L, Lucini V, Carrabba G et al. Simultaneous inhibition of glioma angiogenesis, cell proliferation and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res.61(24), 8730–8736 (2001).
   PubMed Web of Science ®Google Scholar
• Kim SK, Cargioli TG, Machluf M et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin. Cancer Res.11(16), 5965–5970 (2005).
   PubMed Web of Science ®Google Scholar
• Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat. Med.9(1), 123–128 (2003).
   PubMed Web of Science ®Google Scholar
• Tang Y, Shah K, Messerli SM et al.In vivo tracking of neural progenitor cell migration to glioblastomas. Hum. Gene Ther.14(13), 1247–1254 (2003).
   PubMed Web of Science ®Google Scholar
• Shah K, Bureau E, Kim DE et al. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann. Neurol.57(1), 34–41 (2005).
   PubMed Web of Science ®Google Scholar
• Lewin M, Carlesso N, Tung CH et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol.18(4), 410–414 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang Z, Jiang Q, Jiang F et al.In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage23(1), 281–287 (2004).
   PubMedGoogle Scholar
• Slotkin JR, Chakrabarti L, Dai HN et al.In vivo quantum dot labeling of mammalian stem and progenitor cells. Dev. Dyn.236(12), 3393–3401 (2007).
   PubMed Web of Science ®Google Scholar
• Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett.5(4), 709–711 (2005).
   PubMed Web of Science ®Google Scholar
• Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood105(1), 420–425 (2005).
   PubMed Web of Science ®Google Scholar
• Wu X, Hu J, Zhou L et al.In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. J. Neurosurg.108(2), 320–329 (2008).
   PubMed Web of Science ®Google Scholar
• Jaiswal JK, Simon SM. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell. Biol.14(9), 497–504 (2004).
   PubMed Web of Science ®Google Scholar
• Muller-Borer BJ, Collins MC, Gunst PR, Cascio WE, Kypson AP. Quantum dot labeling of mesenchymal stem cells. J. Nanobiotechnology5, 9 (2007).
   PubMedGoogle Scholar
• Ohyabu Y, Kaul Z, Yoshioka T et al. Stable and non-disruptive in vitro/in vivo labeling of mesenchymal stem cells by internalizing quantum dots. Hum. Gene Ther.20(3), 217–224 (2009).
   PubMedGoogle Scholar
• Pike-Overzet K, van der Burg M, Wagemaker G, van Dongen JJ, Staal FJ. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol. Ther.15(11), 1910–1916 (2007).
   PubMed Web of Science ®Google Scholar
• Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther.15(10), 739–752 (2008).
   PubMed Web of Science ®Google Scholar
• Yeager TR, Reddel RR. Constructing immortalized human cell lines. Curr. Opin Biotechnol.10(5), 465–469 (1999).
   PubMedGoogle Scholar
• Hall B, Dembinski J, Sasser AK et al. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol.86(1), 8–16 (2007).
   PubMed Web of Science ®Google Scholar
• Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature416(6880), 542–545 (2002).
   PubMed Web of Science ®Google Scholar
• Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature416(6880), 545–548 (2002).
   PubMed Web of Science ®Google Scholar
• Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N. Engl. J. Med.353(8), 811–822 (2005).
   PubMed Web of Science ®Google Scholar
• Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat. Rev. Cancer6(6), 425–436 (2006).
   PubMed Web of Science ®Google Scholar
• Fomchenko EI, Holland EC. Stem cells and brain cancer. Exp. Cell Res.306(2), 323–329 (2005).
   PubMed Web of Science ®Google Scholar
• Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod. Pathol.14(5), 506–514 (2001).
   PubMed Web of Science ®Google Scholar
• Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res.62(18), 5351–5357 (2002).
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang ZG, Li Y et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res.92(6), 692–699 (2003).
   PubMed Web of Science ®Google Scholar
• Tso CL, Shintaku P, Chen J et al. Primary glioblastomas express mesenchymal stem-like properties. Mol. Cancer Res.4(9), 607–619 (2006).
   PubMedGoogle Scholar
• Ohlsson LB, Varas L, Kjellman C, Edvardsen K, Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp. Mol. Pathol.75(3), 248–255 (2003).
   PubMed Web of Science ®Google Scholar
• De Kok IJ, Drapeau SJ, Young R, Cooper LF. Evaluation of mesenchymal stem cells following implantation in alveolar sockets: a canine safety study. Int. J. Oral Maxillofac. Implants20(4), 511–518 (2005).
   PubMedGoogle Scholar
• Chen J, Wang C, Lu S et al.In vivo chondrogenesis of adult bone-marrow-derived autologous mesenchymal stem cells. Cell Tissue Res.319(3), 429–438 (2005).
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood99(10), 3838–3843 (2002).
   PubMed Web of Science ®Google Scholar
• Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH. Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood103(5), 1941–1948 (2004).
   PubMed Web of Science ®Google Scholar
• Bexell D, Gunnarsson S, Tormin A et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther.17(1), 183–190 (2009).
   PubMed Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet345(8956), 1008–1012 (1995).
   PubMed Web of Science ®Google Scholar
• Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol.20(11), 1111–1117 (2002).
   PubMed Web of Science ®Google Scholar